JPMorgan lowered the firm’s price target on Imax (IMAX) to $26 from $27 and keeps a Neutral rating on the shares. The firm updated its model for Imax, citing risks related to China and exhibitor capex amid the trade war.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- China to ‘moderately reduce’ imported U.S. films over tariffs
- IMAX’s Resilience and Growth Potential in China: Buy Rating Affirmed Amid Market Uncertainties
- Toho Cinemas, Imax expand partnership with Japan
- Imax unveils expansion of its IMAX Enhanced program
- IMAX to expand, upgrade across 80 AMC Theatres in U.S.